文献速递胰腺与胆道疾病消化内镜

超声内镜引导下胆囊引流术治疗急性胆囊炎高手术风险患者:采用电灼增强管腔并置金属支架装置

EUS-guided gallbladder drainage in patients with acute cholecystitis and high surgical risk using an electrocautery-enhanced lumen-apposing metal stent device.
PubMed 文献 · Gastrointest Endosc · 2017-03-01

本研究回顾性纳入7家三级转诊中心的高手术风险急性胆囊炎患者,采用新型电灼增强管腔并置金属支架(ECE-LAMS)行超声内镜引导下胆囊引流术(EUS-GBD)。共75例患者,技术成功率98.7%、临床成功率95.9%,总体不良事件发生率10.7%。作者认为该装置安全且成功率高,但需未来多中心研究比较EUS-GBD与经皮经肝胆囊引流术(PTGBD)。

要点

  • 高手术风险急性胆囊炎患者行EUS-GBD的技术成功率为98.7%,临床成功率为95.9%。
  • 总体不良事件发生率为10.7%,包括穿孔、出血、复发性胆囊炎、支架移位和Bouveret综合征。
  • 作者认为新型ECE-LAMS安全且成功率高,但需未来多中心研究比较EUS-GBD与PTGBD。

核心结论

  • 作者认为,新型ECE-LAMS用于高手术风险急性胆囊炎患者是安全的,技术成功率和临床成功率高。
  • 作者提出需未来多中心研究比较EUS-GBD与PTGBD,以确定哪种操作对高手术风险急性胆囊炎患者更安全、临床更有效。

研究设计与样本

  • 回顾性研究,从7家三级转诊中心检索接受新型ECE-LAMS行EUS-GBD的高手术风险急性胆囊炎患者。
  • 共纳入75例患者,平均年龄75±11岁,其中男性36例。

主要发现

  • 技术成功率为98.7%,临床成功率为95.9%。
  • 3例胆囊炎未缓解的患者死亡;2例发生操作相关不良事件:1例穿孔需手术,1例大出血经保守治疗缓解。
  • 整个队列平均随访201±226天;7例(9.6%)在最初30天内死亡;50例(71.4%)在末次随访日期时存活。
  • 6例患者发生短期和长期不良事件:3例复发性胆囊炎、2例支架移位、1例Bouveret综合征,均经非手术治疗。
  • 整个队列共发生8例不良事件(10.7%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: In high-risk surgical patients, the treatment of choice of acute cholecystitis is percutaneous transhepatic gallbladder drainage (PTGBD). Recently, a novel endoscopic device containing a lumen-apposing metal stent with an electrocautery (ECE-LAMS) on the tip has been developed. METHODS: High-risk surgical patients with acute cholecystitis who underwent EUS-guided gallbladder drainage (EUS-GBD) with the novel device were retrospectively retrieved from 7 tertiary care referral centers. Main endpoints were technical and clinical success rates, rate of procedural adverse events, and short- and long-term adverse events. RESULTS: Seventy-five patients (mean age, 75 ± 11 years; 36 men) underwent EUS-GBD. The procedure was technically and clinically successful in 98.7% and 95.9% of cases, respectively. Three patients without resolution of cholecystitis died, and 2 patients had procedure-related adverse events: 1 perforation requiring surgery and 1 major bleeding resolved conservatively. The mean follow-up for the entire cohort was 201 ± 226 days. Seven patients (9.6%) died within the first 30 days; 50 patients (71.4%) were alive at the last date of follow-up. Short- and long-term adverse events occurred in 6 patients: 3 had recurrent cholecystitis, 2 had migration of the stent, and 1 developed Bouveret syndrome, all managed nonsurgically. Overall, 8 adverse events (10.7%) occurred in the entire cohort of patients. CONCLUSIONS: The novel ECE-LAMS for high-risk surgical patients with acute cholecystitis is safe, with a high technical and clinical success rate. Future multicenter studies comparing EUS-GBD versus PTGBD are warranted to determine which procedure is safer and clinically more effective for patients with high surgical risk acute cholecystitis.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Dollhopf M, Larghi A, Will U, et al. EUS-guided gallbladder drainage in patients with acute cholecystitis and high surgical risk using an electrocautery-enhanced lumen-apposing metal stent device. Gastrointest Endosc. 2017. PMID: 28259594. doi:10.1016/j.gie.2017.02.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。